<scp>Real‐world</scp> efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real‐world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours

Published:2022-04-29 Issue:6 Volume:34 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinology

Author:

Almeamar Hussein¹^ORCID,Cullen Lisa¹,Murphy David J.²³^ORCID,Crowley Rachel K.¹³,Toumpanakis Christos⁴,Welin Staffan⁵,O'Shea Donal¹³,O'Toole Dermot¹⁶

Affiliation:

1. National Centre for Neuroendocrine Tumours, ENETS Centre of Excellence St. Vincent's University Hospital Dublin Ireland

2. Department of Radiology St. Vincent's University Hospital Dublin Ireland

3. UCD School of Medicine Dublin Ireland

4. ENETS Centre of Excellence Royal Free Hospital London UK

5. Department of Endocrine Oncology, ENETS Centre of Excellence Uppsala University Hospital Uppsala Sweden

6. Department of Clinical Medicine Trinity College Dublin Dublin Ireland

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jne.13138

Reference31 articles.

1. Carcinoid Tumors

2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

3. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photoionization cross sections measurements of the excited states of lutetium and ytterbium in the near threshold region;The Journal of Chemical Physics;2024-04-25

2. Management of neuroendocrine tumor liver metastases;The American Journal of Surgery;2023-11

3. Lutetium-(177lu)-oxodotreotide;Reactions Weekly;2023-07-01

4. The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database;Frontiers in Oncology;2022-10-06

5. Application Prospect of Radionuclide Tracer Technology in Clinical Imaging Therapy and Drug Development;Highlights in Science, Engineering and Technology;2022-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3